4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001415889-25-017446
Director bought 163,287 shares at an average $10.19 ($1,664,700)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-06-12 | Purchase | +31,307 | $10.20 | $319,331 | 10,127,311 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-06-13 | Purchase | +120,167 | $10.20 | $1,225,703 | 10,247,478 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-06-16 | Purchase | +11,813 | $10.13 | $119,666 | 10,259,291 | I |
| Open-market purchases · 163,287 sh · avg $10.19 · $1,664,700 | |||||||
Loading xslF345X05/form4-06172025_120645.xml…